N-Ethylhexedrone was patented because of the German pharmaceutical company Boehringer Ingelheim in 1964 as a possible anorexigenic agent. The patent describes its synthesis along with other derivatives of aminoketone.[1] The cognitive results of mephedrone may be damaged down into several par